MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

COLLABORATION

Metabolon to perform metabolomic analysis for Lactation Lab

Metabolon collaborates with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center (BIDMC) in a first-of-its-kind Lactation Lab to improve maternal and infant health. Read More
COMPANY NEWS

Metabolon Continues Investments in Scientific Innovation

Appointment of Rangaprasad (Ranga) Sarangarajan, Ph.D., in New Leadership Role as Chief Scientific Officer Read More
ADVANCING SCIENCE

New Hope for Rare Disease Treatments

Metabolon’s clinical metabolomics efficacy biomarkers support FDA approval of off-label treatment for rare disease, enabling successful therapy for first-in-world patient. Read More
COMPANY NEWS

Metabolon collaborates with Cleveland Clinic to enable novel discoveries

“Metabolomics is an essential element of the multi-omics approach that is being employed by Cleveland Clinic to transform healthcare by understanding disease progression and therapeutic response more deeply.” Read More

Working with Metabolon

Metabolon deciphers thousands of discrete chemical signals from genetic and non-genetic factors to discover biomarkers and reveal biological pathways. We make connections where other ‘omics cannot, and provide the definitive representation of the phenotype.

Talk With an Expert About Your Study

Personalized guidance at every step

From study design to sample collection, report visualization to biological interpretation, Metabolon experts guide you every step of the way.

Learn More
Metabolon Launches Meta UDx™ Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and Adults
Chart the best course

With expertise honed over more than 10,000 projects, our early study design guidance can help ensure your study is properly powered, properly controlled and aligned to your research objectives.

Build a strong foundation

The quality of your sample is everything. Our Sample Prep team provides time-tested sample collection and handling guidelines for collection and storage, volume requirements and tube selection to ensure you are prepped for success, right from the start.

Harness the power of historical insight at industrial scale

Our integrated bioinformatics solution makes it possible to efficiently and accurately mine the world’s largest Tier 1 metabolomics compound library for every study, to ensure consistently reliable results, every time.

Precisely powerful platform

Metabolon’s global Precision Metabolomics™ LC-MS platform can help detect more unique metabolites than any other platform.

Rise above the noise

Voluminous metabolomics data sets are often riddled with noisy ion features. Our highly trained curation staff has the skills and technical expertise to confidently navigate large data sets to deliver a reliable, high-fidelity view of your results.

We take you beyond the data

Our Discovery and Translational Science experts elevate meaningful biological insights from pages of spreadsheet data to help narrate a comprehensive and credible story of your research discoveries.

Metabolon - Metabolomics

About Metabolomics

Small molecules, big insights

Metabolomics can provide a unique, real-time fingerprint of your biological system to reveal novel discoveries and realize the promise of precision medicine.

Learn More

A trusted partner for 20 years

1,300+ clients. 10,000 projects. Learn why researchers around the world have put their trust in Metabolon for two decades.

See All Stories

“At Siolta, we are utilizing both untargeted and targeted metabolomic approaches to help characterize the overall metabolic signatures associated with treatment and response and potentially provide insight into patient stratification for more precise therapeutic approaches moving forward.”

VIEW CLIENT STORY

NikoleKimes-profile
Nikole Kimes, Ph.D.
Co-Founder & CEO
Siolta

“Living in a microscopic world, cells communicate with each other by speaking in small molecules. We’re seeing a conversation happen between the microbiome and body, and metabolomics allows us to listen to the language spoken by the microbiome to the body.”

VIEW CLIENT STORY

testimonial-seangibbons
Sean M. Gibbons, Ph.D.
Assistant Professor
Institute for Systems Biology, Washington Research Foundation Distinguished Investigator

“Metabolites are the physical interface between circadian clocks and metabolism – they communicate between tissues.”

VIEW CLIENT STORY

testimonial-PaoloSassone-Corsi
Paolo Sassone-Corsi, Ph.D.
Donald Bren Professor and Director of the Center for Epigenetics and Metabolism
University of California, Irvine

“In addition to our industry-leading OMNIgene® collection devices for metagenomics, customers were asking for an ambient-temperature collection and storage solution for microbiome metabolomics samples. Working with Metabolon, the clear metabolomics market leader, the OMNImet®·GUT device provides scientists with an important new solution for metabolomics research and builds on our evolution towards a fully integrated multiomics company that creates and captures value from sample collection all the way to discovery”

VIEW COLLABORATION STORY

Scott Rabuka
Scott Rabuka
Senior Director, Molecular Products
DNA Genotek Inc.

Enlighten your research,
accelerate your discovery.

Demo Our Data
or Talk With an Expert

Latest Insights & News

Visit our blog
How Metabolomics Can Raise the Bar in Drug Development
22 March 2022

How Metabolomics Can Raise the Bar in Drug Development

An Interview with Metabolon Chief Scientific Officer Ranga Sarangarajan, Ph.D. So why has this recognized R&D leader now chosen to focus on metabolomics? We sat down with Ranga to get his take on this rapidly growing technology and the potential it holds to propel drug development.
Metabolon Announces Chief Financial Officer Transition
14 February 2022

Metabolon Announces Chief Financial Officer Transition

“We are thrilled to welcome Gerry to Metabolon during this strategic growth phase as we expand the use of metabolomics across the life sciences, including drug discovery and development. Gerry has a strong track record of success as a multi-faceted CFO, leading companies spanning the high-tech, biotech, medtech, and manufacturing sectors,” said Rohan Hastie, Ph.D., President and CEO of Metabolon.
Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen
24 January 2022

Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen

As a leading biobank research project based in Finland, FinnGen will incorporate deep metabolomic datasets to better understand how genetic drivers of disease may impact biological function and influence disease progression.

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Quality Assurance
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events
  • Publications

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

in